Top 5 Asian Healthcare Stocks for 2021
Here are five picks in a sector whose private- and public-sector support is sure to continue as Asia ages.
HCA Healthcare's Technical Strategy and Price Targets Are Positive
The charts are generally bullish and HCA could head up towards $200, but there are some caveats.
Hain Celestial's Base Could Support Further Price Gains
The shares have doubled from their March nadir.
The Pullback in Alphatec Should Offer a Strong Entry on Thursday's Breakout
My preference here is to target an option that will work more like a stock replacement approach.
Telehealth Isn't Just for People Anymore
A look at the fast-growing field of telehealth, both for people and, as a less-well known market, for pets.
It's Time to Reveal the First 4 Ugly Ducklings of This Deep-Value Portfolio
A drugstore giant, a maker of office technology, a chicken producer and a shoe seller make up one-third of the 2021 Tax Loss Selling Recovery Portfolio.
A New Strategy as Moderna's Charts Point to Further Gains
Here's where I'd consider taking profits.
What If AstraZeneca's Covid-19 Vaccine Doesn't Work?
Governments around the world have committed to buying hundreds of millions of doses of AZD1222.
Thankful for Life, Sloppy Wednesday, Sizing Up Salesforce, Keep on Fighting
The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.
Centene Is Still Not Showing Us the Right Stuff
Here's our analysis and trading strategy for CNC shares.